Eton Pharmaceuticals, Inc. ETON Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $24.27M+14.0% | $21.28M-5.2% | $22.46M+18.7% | $18.93M+9.5% | $17.28M+48.4% | ||
| $9.53M+16.5% | $8.18M-44.0% | $14.6M+109% | $7M-5.6% | $7.42M+43.5% | ||
| $14.74M+12.5% | $13.1M+66.8% | $7.86M-34.1% | $11.92M+20.9% | $9.86M+52.3% | ||
| 60.7%-0.8pp | 61.6%+26.6pp | 35%-28.0pp | 63%+5.9pp | 57.1%+1.5pp | ||
| $1.88M+5.3% | $1.78M+60.1% | $1.11M-70.0% | $3.71M+220% | $1.16M— | ||
| $10.45M+18.0% | $8.86M+9.3% | $8.11M-16.3% | $9.69M+5.6% | $9.17M+36.5% | ||
| $12.32M+15.8% | $10.64M+15.4% | $9.22M-31.2% | $13.4M+29.7% | $10.33M+76.7% | ||
| $2.41M— | —— | -$1.36M+7.6% | -$1.48M-214% | -$470K— | ||
| 9.9%— | —— | -6.1%+1.7pp | -7.8%-5.1pp | -2.7%— | ||
| -$840K— | —— | -$592K+43.3% | -$1.04M-1.6% | -$1.03M— | ||
| $1.57M— | —— | -$1.96M+22.4% | -$2.52M-68.2% | -$1.5M-193% | ||
| $20K— | —— | -$28K-142% | $66K-10.8% | $74K-14.9% | ||
| $1.55M— | —— | -$1.93M+25.5% | -$2.59M-64.4% | -$1.57M-163% | ||
| 6.4%— | —— | -8.6%+5.1pp | -13.7%-4.6pp | -9.1%-4.0pp | ||
| $0.05— | —— | -$0.07— | —— | -$0.06— | ||
| $3.55M— | —— | -$354K+24.7% | -$470K-187% | $543K+448% | ||
| 14.6%— | —— | -1.6%+0.9pp | -2.5%-5.6pp | 3.1%+4.5pp | ||
| $2.41M— | —— | -$1.36M+7.6% | -$1.48M-214% | -$470K+8.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s revenue?
- Eton Pharmaceuticals, Inc. (ETON) generated $86.9M in revenue over the trailing twelve months, up 79.9% year over year.
- Is Eton Pharmaceuticals, Inc. profitable?
- Eton Pharmaceuticals, Inc. is not currently profitable: it reported a net loss of $4.5M over the trailing twelve months, a -9.5% net margin.
- What are Eton Pharmaceuticals, Inc.'s profit margins?
- Gross margin is 54.8% and operating margin is -15.1%, with a -9.5% net margin.
- What is Eton Pharmaceuticals, Inc.'s earnings per share?
- Eton Pharmaceuticals, Inc.'s diluted EPS over the trailing twelve months is $-0.06.
- Where does Eton Pharmaceuticals, Inc.'s income statement data come from?
- Every line is extracted from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
